Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Market Cap	365.31B
Revenue (ttm)	10.95B
Net Income (ttm)	2.79B
Shares Out	8.13M
EPS (ttm)	-255.76
PE Ratio	130.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,117
Average Volume	108,371
Open	47,450
Previous Close	47,500
Day's Range	45,900 - 47,800
52-Week Range	21,400 - 60,800
Beta	n/a
RSI	58.65
Earnings Date	n/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 389650